 People living with type 2 diabetes can now take Rybelsus, the first and only oral glucagon-like peptide-1 GLP-1 analog, along with diet and exercise, as initial therapy to help lower their A1C1,2 Since its approval, Rybelsus has been prescribed to hundreds of thousands of patients to help improve glycemic control along with diet and exercise3 PLAINSBORO, ...... 